Aligning with our hypothesis, previous studies on ovarian carcinoma [19] and endometrioid endometrial carcinoma [20] conveyed that HAND2-AS1 expression could negatively correlate with its promoter CpG island methylation. The gene discussed is HAND2; the disease is endometrial endometrioid carcinoma.